Phaseline

Companies › CellTherX

CellTherX: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 4; Other.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
microsurfaced split thickness skin graft
Cadaveric split thickness skin graft with microsurfacing treatment to enhance graft take a
–Phase 4Burns–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04589442microsurfaced split thickness skin graftPhase 4BurnsOtherAug 2021

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

CUTISS Gameto Merz Aesthetics DBV Technologies Merz North America

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.